Open AccessTargeting CYP450 modulation to decrease the risk of induced cataract in the experimental model
Author(s) -
Dimpy Patel,
Tejal Gandhi,
Kirti Patel,
D. B. Patil,
P.V. Parikh
Publication year - 2010
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.71676
Subject(s) - inducer , medicine , glutathione , endocrinology , pharmacology , diabetes mellitus , galactose , biochemistry , enzyme , chemistry , gene
Diabetes is one of the major causes of cataract. Some drugs prescribed for the treatment of diabetes are the modulators of CYP450, which may alter the risk of cataract.